Science & medicine news
-
Hiding in plain sight: Improved CAR T-cell therapy for T-cell acute lymphoblastic leukemia
St. Jude scientists developed a simple method to select for more effective cancer-destroying CAR T cells to treat T-ALL.
-
Getting more mileage from a T-cell therapy for AML
St. Jude scientists have created a proof-of-principle approach to improve engager T-cell therapy for difficult-to-treat acute myeloid leukemia.
-
St. Jude Graduate School of Biomedical Sciences awards degrees in global child health
Degrees were awarded to 9 students from 8 countries. Ten international students who graduated in 2021 also participated in the ceremony.
-
Frank Fazio named president of Children's GMP and vice president of therapeutics production and quality at St. Jude
The Good Manufacturing Practices (GMP) facility produces highly specialized biopharmaceuticals and other biological products for the hospital’s clinics.
-
Genetics weigh heavy on childhood cancer survivors’ risk of developing obesity
St. Jude scientists created a way to identify childhood cancer patients at diagnosis who are at the highest risk for developing severe obesity as adults.
-
Study reveals a new therapeutic target for aggressive type of rhabdomyosarcoma
Scientists at St. Jude found an Achilles’ heel in rhabdomyosarcoma driven by a gene fusion which revealed a promising treatment approach in the lab.